Revvity (RVTY) CEO Singh logs new grants, option exercise and sales
Rhea-AI Filing Summary
Revvity, Inc. insider Prahlad R. Singh, President, Chief Executive Officer and Director, reported multiple equity transactions dated February 4–5, 2026. On February 4, 3,421 shares of common stock were surrendered at $101.13 per share to cover tax withholding on vested restricted stock, and 26,796 time-based restricted stock units were granted, scheduled to vest in three equal annual installments beginning on the first anniversary of grant.
Singh also received a nonqualified stock option for 76,647 shares at an exercise price of $103.395, vesting in three equal annual installments beginning on the first anniversary of grant. On February 5, a previously granted option for 25,525 shares at $92.09 was exercised, and the resulting 25,525 shares of common stock were acquired, followed by market sales totaling 1,307, 12,186, 7,885, 3,079 and 1,068 shares at weighted average prices between $99.02 and $102.52, executed under a Rule 10b5-1 trading plan adopted on February 6, 2025.
After these transactions, Singh reported 120,213 shares of Revvity common stock held directly. An additional 46,583 shares are held indirectly by the Singh Family Trust of 2021 for the sole benefit of his children, with beneficial ownership disclaimed except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | NQ Stock Option (right to buy) | 25,525 | $0.00 | -- |
| Exercise | Common Stock | 25,525 | $92.09 | $2.35M |
| Sale | Common Stock | 1,307 | $99.02 | $129K |
| Sale | Common Stock | 12,186 | $99.55 | $1.21M |
| Sale | Common Stock | 7,885 | $100.63 | $793K |
| Sale | Common Stock | 3,079 | $101.45 | $312K |
| Sale | Common Stock | 1,068 | $102.52 | $109K |
| Grant/Award | NQ Stock Option (right to buy) | 76,647 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,421 | $101.13 | $346K |
| Grant/Award | Common Stock | 26,796 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement. Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.